Qi Wang from UOB Kay Hian says he is approaching the China markets with a barbell strategy: being defensive by investing in ...

Antibody therapies constitute a vast global market: currently valued at over $250 billion, the market for antibodies is ...

Breakthrough proteomics platform technology unlocks full-length protein sequencing and characterisation, accelerating drug ...

AI implementation in Bengaluru hospital reduces manual work, reshapes workforce, and raises concerns about job displacement ...

The technology can be transformative across our economy and national defense, but not if developers have to face 50 different ...

The AI revolution is driving tension between new technology and the traditional approaches in drugmaking. Biopharma leaders ...

The scheme is aimed at fostering local innovation and reducing reliance on foreign patents. It targets diverse industries, ...

AI has been a buzzword in the pharmaceutical industry for almost a decade, with countless headlines promising to ...

Recent technological advancements have made recovery from paralysis a real possibility for the first time in history.

A deal between Shenzhen-based XTalPi and US firm DoveTree shows Chinese biotech AI capabilities are gaining recognition.

LogicFlo AI, an AI platform based in Boston, has secured $2.7 million in seed funding led by Lightspeed, with contributions ...

India's tech ecosystem in 2025 showcases a strategic blend of AI, quantum, biotech, and digital infrastructure—powering ...